These findings suggest that exploring the non-canonical activity of AURKA, namely studying the action and mechanism of abnormal RNA splicing mediated by AURKA, will provide new opportunities for targeted therapy of lung cancer. The gene discussed is AURKA; the disease is lung carcinoma.